Related Experiment Video

Updated: Mar 29, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

Cardiovascular System Changes and Related Risk Factors in Acromegaly Patients: A Case-Control Study

Xiaopeng Guo1, Lu Gao1, Shuo Zhang2

  • 1Department of Neurosurgery, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Beijing 100730, China ; Peking Union Medical College, No. 5 Dongdansantiao, Beijing 100730, China.

International Journal of Endocrinology
|November 25, 2015
PubMed

Insights

Acromegaly patients show significant cardiac changes, including larger heart cavities and thicker walls. Aging and obesity are key risk factors for this acromegalic cardiomyopathy.

Area of Science:

  • Cardiology
  • Endocrinology

Background:

  • Acromegaly is associated with cardiovascular complications impacting life expectancy and quality of life.
  • Understanding these cardiovascular changes and their risk factors is crucial for patient management.

Purpose of the Study:

  • To investigate cardiovascular alterations in acromegaly patients.
  • To identify risk factors associated with these cardiac changes.

Main Methods:

  • A case-control study involving 108 acromegaly patients and 108 matched controls.
  • Standard echocardiography was performed on all participants.

Main Results:

  • Acromegaly patients exhibited structural cardiac changes: larger heart cavities, thicker myocardial walls, and increased great vessel diameters.
  • Reduced diastolic function was observed in acromegaly patients.
  • Aging and increased body mass index (BMI) correlated with myocardial hypertrophy and diastolic dysfunction.
  • Longer disease duration correlated with increased great vessel diameters.

Conclusions:

  • Aging and increased BMI are independent risk factors for acromegalic cardiomyopathy.
  • Prolonged disease duration contributes to great vessel expansion.
  • Early diagnosis and weight management are recommended for acromegaly patients.

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
751
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
697
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
1.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
664
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
5.1K